SNCA and Parkinson disease: Parkinson’s disease (PD) is classically characterized by loss of nigrostriatal dopamine (DA) neurons in the midbrain, formation of intraneuronal alpha-synuclein (α-syn) positive Lewy bodies and Lewy neurites, and development of cardinal motor symptoms that include bradykinesia, resting tremor, rigidity, and postural instability.